Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.60 7.86% 63.10 62.00 64.20 63.60 58.00 58.50 395,565 11:06:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.6 -1.2 - 98

SkinBioTherapeutics PLC Holding(s) in Company

01/02/2021 11:21am

UK Regulatory (RNS & others)


TIDMSBTX

RNS Number : 5569N

SkinBioTherapeutics PLC

01 February 2021

TR-1: S tandard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible) (i) 
 
 1a. Identity of the issuer or the                                      SkinBioTherapeutics plc 
  underlying issuer of existing shares 
  to which voting rights are attached                                Company No: 09632164 (England) 
  (ii) : 
                                                             --------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                    ------ 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                           x 
                                                                                                    ------ 
 An acquisition or disposal of financial instruments 
                                                                                                    ------ 
 An event changing the breakdown of voting rights 
                                                                                                    ------ 
 Other (please specify)(iii) : 
                                                                                                    ------ 
 3. Details of person subject to the notification obligation (iv) 
 Name                                                         Seneca Partners Limited 
 City and country of registered office                        Haydock, Greater Manchester UK 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.) (v) 
 Name                                                         Share Nominees Limited, WCS Nominees 
                                                               Limited, Platform Securities Nominees 
                                                               Limited. 
                                                             --------------------------------------------- 
 City and country of registered office                        Aylesbury, Bucks, UK, London UK 
  (if applicable) 
                                                             --------------------------------------------- 
 5. Date on which the threshold was                           29/01/2021 
  crossed or reached (vi) : 
                                                             --------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):               01/02/2021 
                                                             --------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights     Total of both   Total number 
                            rights attached      through financial      in % (8.A +     of voting rights 
                            to shares (total        instruments             8.B)        of issuer (vii) 
                                of 8. A)           (total of 8.B 
                                                     1 + 8.B 2) 
                          ------------------  ----------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached               12.9                                        12.9            155,889,922 
                          ------------------  ----------------------  --------------  -------------------- 
 Position of 
  previous notification 
  (if 
  applicable)              13.5                                        13.5 
                          ------------------  ----------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which the 
  threshold was crossed or reached (viii) 
 A: Voting rights attached to shares 
 Class/type of        Number of voting rights (ix)                                % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                                Direct                       Indirect                       Direct                      Indirect 
                          (Art 9 of Directive          (Art 10 of Directive           (Art 9 of Directive          (Art 10 of Directive 
                             2004/109/EC)                  2004/109/EC)              2004/109/EC) (DTR5.1)             2004/109/EC) 
                               (DTR5.1)                     (DTR5.2.1)                                                  (DTR5.2.1) 
                                                  ----------------------------- 
 Ordinary Shares 
 
  GB00BF33H870                 20,110,387          N/A                            12.9                          N/A 
                     ---------------------------  -----------------------------  ----------------------------  -------------------------- 
 
 
 
 SUBTOTAL 8. A                                    20,110,387                                               12.9 
                     ----------------------------------------------------------  -------------------------------------------------------- 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of financial    Expiration        Exercise/                        Number of voting                       % of voting 
  instrument           date              Conversion Period                rights that may                        rights 
                       (x)               (xi)                             be acquired if the 
                                                                          instrument is 
                                                                          exercised/converted. 
                     ----------------  -------------------------------  -------------------------------------  -------------------------- 
 
 
 
                                        SUBTOTAL 8. B 1 
                                       -------------------------------  -------------------------------------  -------------------------- 
 
 B 2: Financial Instruments with similar economic effect according to Art. 
  13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of       Expiration               Exercise/               Physical or                Number of            % of voting 
  financial     date (x)                 Conversion              cash                       voting rights        rights 
  instrument                             Period (xi)             settlement 
                                                                 (xii) 
              -----------------------  ----------------------  -------------------------  ------------------- 
 
 
 
                                                                SUBTOTAL 8.B.2 
                                                               -------------------------  ------------------- 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled                                                               x 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer (xiii) 
 Full chain of controlled undertakings through which the voting rights 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity (xiv) (please add additional 
  rows as necessary) 
         Name (xv)                  % of voting rights                 % of voting rights                  Total of both if 
                                      if it equals or                   through financial                   it equals or is 
                                    is higher than the                  instruments if it                   higher than the 
                                   notifiable threshold                equals or is higher               notifiable threshold 
                                                                       than the notifiable 
                                                                            threshold 
                            ---------------------------------  ----------------------------------  ------------------------------- 
 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                                               ------------------------------------------------------------------- 
 The number and % of voting rights 
  held 
                                                               ------------------------------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                                               ------------------------------------------------------------------- 
 
 11. Additional information (xvi) 
 
 
 
 
 Place of completion   Haydock, Greater Manchester UK 
 Date of completion    1 February 2021 
                      ------------------------------- 
 
, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLTBMBTMTBMBPB

(END) Dow Jones Newswires

February 01, 2021 06:21 ET (11:21 GMT)

1 Year Skinbiotherapeutics Chart

1 Year Skinbiotherapeutics Chart

1 Month Skinbiotherapeutics Chart

1 Month Skinbiotherapeutics Chart
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210421 11:31:22